v3.25.4
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Summary of net loss reconciliation

Years Ended December 31,

2025

  ​ ​ ​

2024

Denifanstat external research and
development expenses

$

28,248

$

33,838

TVB-3567 external research and development
expenses

 

6,084

 

810

External general and administrative expenses

8,760

8,001

Personnel costs

7,150

6,517

Stock-based compensation

 

6,449

 

5,288

Other segment items (1)

(5,653)

(8,887)

Segment net loss

$

51,038

$

45,567

___________

(1)Other segment items consist of (i) interest and other income, net and (ii) other internal operating research and development expenses.